Fangda Holdings (01521) received a premium of about 59.1%, privatized and resumed trading on November 10

According to Zhitong Finance App News, Fangda Holdings (01521) and the offender SanRex Limited jointly announced that on November 9, 2026, the offeror signed an implementation agreement with the company. Based on this, the contracting party has agreed to make every reasonable effort to implement the proposal to privatize the company through planning arrangements in accordance with section 86 of the Company Law. If the proposal is approved and implemented, the cancellation price for each planned share is HK$2.370, which is approximately 59.1% premium over the closing price of HK$1.490 per share reported on the Stock Exchange on the last trading day.

After the plan comes into effect, all plan shares will be cancelled (at the same time, an equal number of new shares will be issued to the offender and recorded as full payment to maintain the company's issued share capital at the amount immediately before cancellation of the plan shares), and the shares of the plan shares will no longer be valid as ownership documents or certificates thereafter. Following the effective date, the company will apply to withdraw the listing status of its shares on the Stock Exchange in accordance with section 6.15 of the listing rules. The company has applied to the Stock Exchange to resume trading of shares on the Stock Exchange from 9:00 a.m. on November 10, 2026 (Hong Kong time).

As of the date of this announcement, the issuer's issued share capital was 2,038,538,910 shares with a face value of $0.00001 per share and owned by CRL, Hong Kong Tiger, Chairman of the Board Dr. Li Song, The Linna Li GST Exempt Trust, The Wendy Li GST Exempt Trust and The Yue Monica Li GST Exempt Trust, respectively, owned 38.27%, 53.40%, 1.63%. 2.24%, 2.24%, and 2.24% equity. As of the date of this announcement, the offender is a non-wholly-owned subsidiary of Tiger Pharmaceuticals, and shares of the offender held by Hong Kong Tiger, Chairman of the Board Dr. Li Song, The Linna Li GST Exempt Trust, The Wendy Li GST Exempt Trust, and The Yue Monica Li GST Exempt Trust have not paid the shares.